| 摘要 |
PURPOSE: A liquid phase product of botulinum toxin and a method for preservating titer of the botulinum toxin are provided to ensure constant treatment result. CONSTITUTION: A liquid phase product of botulinum type A toxin is prepared by: adding a dextrose solution, and adding 2-6 ml of 6-12% dextrose solution per 100 units and dissolving. The liquid phase product additionally contains anesthetic such as lidocaine, tetracaine, bupivacaine, or dibucaine. |
